Literature DB >> 24896804

Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir.

Eva Van den Eynde1, Elena Ferrer, Daniel Podzamczer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24896804     DOI： 10.1097/QAD.0000000000000265

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Effect of hepatitis B and C clearance on atazanavir exposure.

Authors:  Cristina Gervasoni; Dario Cattaneo; Valeria Micheli; Valentina Di Cristo; Laura Milazzo
Journal:  Eur J Clin Pharmacol       Date:  2015-08-23       Impact factor: 2.953

2.  Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.

Authors:  Meghan E Sise; Elke S Backman; Julia B Wenger; Brian R Wood; Paul E Sax; Raymond T Chung; Ravi Thadhani; Arthur Y Kim
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 3.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.